Lv51
1575 积分 2020-04-20 加入
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
6小时前
待确认
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
7小时前
已完结
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
9个月前
已完结
Passive anti-amyloid β immunotherapy in Alzheimer's disease—opportunities and challenges
10个月前
已完结
Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
1年前
已完结
Toxicologic Neuropathology of Novel Biotherapeutics
1年前
已完结
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
1年前
已完结
Transforming obesity: The advancement of multi-receptor drugs
1年前
已完结
Oligonucleotide therapeutics and their chemical modification strategies for clinical applications
1年前
已完结
LBP-048 Preclinical proof of concept and discovery of siRNA therapeutics targeting CIDEB for metabolic dysfunction-associated steatohepatitis
1年前
已完结
皖公网安备34019202002308
